Report cover image

France Immunoassay Market Size, Share, Trends, Industry Analysis Report By Product (Reagents & Kits, Analyzers/Instruments), By Technology, By Specimen, By Application, By End Use – Market Forecast, 2025–2034

Publisher Polaris Market Research & Consulting LLP
Published Aug 01, 2025
Length 129 Pages
SKU # PLRS20381470

Description

The France Immunoassay Market size is expected to reach USD 1,602.94 million by 2034, according to a new study by Polaris Market Research. The report “France Immunoassay Market Share, Size, Trends, Industry Analysis Report By Product (Reagents & Kits, Analyzers/Instruments), By Technology, By Specimen, By Application, By End Use; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

An immunoassay refers to an antibody-based analytical method used to detect the presence or concentration of target molecules with high specificity and sensitivity. The France immunoassay market is driven by the shift toward automation and high-throughput screening platforms, which are transforming diagnostic workflows across clinical laboratories. Automated immunoassay systems are being increasingly adopted to reduce manual error, enhance consistency, and support large-volume testing, as demand increases for faster and more accurate results. This technological evolution is contributing to improved diagnostic precision and better patient outcomes, aligning with the country’s broader focus on healthcare efficiency.

The integration of immunoassays into personalized medicine approaches drives the France immunoassay market expansion opportunities. Immunoassays are proving instrumental in monitoring disease biomarkers and treatment responses with greater precision, as clinical decisions become more tailored to individual patient profiles. This personalized approach to diagnostics enables earlier intervention and more targeted therapies, reinforcing the strategic value of immunoassay technologies in clinical practice. The growing relevance of these tests in personalized healthcare frameworks highlights their expanding role in supporting France’s modern diagnostic ecosystem.

France Immunoassay Market Report Highlights

In terms of product, the reagents & kits segment accounted for USD 749.92 million revenue share in 2024, driven by widespread use in clinical diagnostics and research labs nationwide.

Based on technology, the rapid tests segment is projected to register a CAGR of 3.3%, fueled by France's shift toward decentralized diagnostics and preventive care for its aging population.

A few key France immunoassay market players include AAZ-LMB, Beckman Coulter, bioMérieux SA, DIAGAST, ELITechGroup SAS, Eurobio Scientific SA, Innovative Diagnostics, NG Biotech, Sebia SAS, and VedaLab.

Polaris Market Research has segmented the France immunoassay market report on the basis of product, technology, specimen, application, and end use:

By Product Outlook (Revenue, USD Million, 2020–2034)

Reagents & Kits

ELISA Reagents & Kits

Rapid Test Reagents & Kits

Western Blot Reagents & Kits

ELISPOT Reagents & Kits

Other Reagents & Kits

Analyzers/Instruments

Open Ended Systems

Closed Ended Systems

Software & Services

By Technology Outlook (Revenue, USD Million, 2020–2034)

Enzyme Immunoassays (EIA)

Chemiluminescence Immunoassays (CLIA)

Fluorescence Immunoassays (FIA)

Rapid Test

Radioimmunoassay (RIA)

Others

By Specimen Outlook (Revenue, USD Million, 2020–2034)

Blood

Urine

Saliva

Others

By Application Outlook (Revenue, USD Million, 2020–2034)

Infectious Disease Testing

Cardiology

Oncology

Endocrinology

Autoimmune Diseases

Therapeutic Drug Monitoring

Others

By End Use Outlook (Revenue, USD Million, 2020–2034)

Hospitals

Laboratories

Others

Table of Contents

129 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Retail and E-Commerce
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. France Immunoassay Market Insights
4.1. France Immunoassay Market – Material Snapshot
4.2. France Immunoassay Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Government Initiatives and Healthcare Modernization
4.2.1.2. Rising Infectious Disease Burden
4.2.2. Restraints and Challenges
4.2.2.1. Regulatory Challenges and Market Fragmentation
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. France Immunoassay Market Material Trends
4.6. Value Chain Analysis
5. France Immunoassay Market, by Product
5.1. Key Findings
5.2. Introduction
5.2.1. France Immunoassay Market, by Product, 2020-2034 (USD Million)
5.3. Reagents & Kits
5.3.1. France Immunoassay Market, by Reagents & Kits, 2020–2034 (USD Million)
5.3.2. ELISA Reagents & Kits
5.3.2.1. France Immunoassay Market, by ELISA Reagents & Kits, 2020–2034 (USD Million)
5.3.3. Rapid Test Reagents & Kits
5.3.3.1. France Immunoassay Market, by Rapid Test Reagents & Kits, 2020–2034 (USD Million)
5.3.4. Western Blot Reagents & Kits
5.3.5. France Immunoassay Market, by Western Blot Reagents & Kits, 2020–2034 (USD Million)
5.3.6. ELISPOT Reagents & Kits
5.3.6.1. France Immunoassay Market, by ELISPOT Reagents & Kits, 2020–2034 (USD Million)
5.3.7. Other Reagents & Kits
5.3.7.1. France Immunoassay Market, by Other Reagents & Kits, 2020–2034 (USD Million)
5.4. Analyzers/Instruments
5.4.1. France Immunoassay Market, by Analyzers/ Instruments, 2020–2034 (USD Million)
5.4.2. Open Ended Systems
5.4.2.1. France Immunoassay Market, by Open Ended Systems, 2020–2034 (USD Million)
5.4.3. Closed Ended Systems
5.4.3.1. France Immunoassay Market, by Closed Ended Systems, 2020–2034 (USD Million)
5.5. Software & Services
5.5.1. France Immunoassay Market, by Software & Services, 2020–2034 (USD Million)
6. France Immunoassay Market, Technology
6.1. Key Findings
6.2. Introduction
6.2.1. France Immunoassay Market, Technology, 2020-2034 (USD Million)
6.3. Enzyme Immunoassays (EIA)
6.3.1. France Immunoassay Market, by Enzyme Immunoassays (EIA), 2020–2034 (USD Million)
6.3.2. Chemiluminescence Immunoassays (CLIA)
6.3.2.1. France Immunoassay Market, by Chemiluminescence Immunoassays (CLIA), 2020–2034 (USD Million)
6.3.3. Fluorescence Immunoassays (FIA)
6.3.3.1. France Immunoassay Market, by Fluorescence Immunoassays (FIA), 2020–2034 (USD Million)
6.4. Rapid Test
6.4.1. France Immunoassay Market, by Rapid Test, 2020–2034 (USD Million)
6.5. Radioimmunoassay (RIA)
6.5.1. France Immunoassay Market, by Radioimmunoassay (RIA), 2020–2034 (USD Million)
6.6. Others
6.6.1. France Immunoassay Market, by Others, 2020–2034 (USD Million)
7. France Immunoassay Market, by Specimen
7.1. Key Findings
7.2. Introduction
7.2.1. France Immunoassay Market, by Specimen, 2020-2034 (USD Million)
7.3. Blood
7.3.1. France Immunoassay Market, by Blood, 2020–2034 (USD Million)
7.4. Urine
7.4.1. France Immunoassay Market, by Urine, 2020–2034 (USD Million)
7.5. Saliva
7.5.1. France Immunoassay Market, by Saliva, 2020–2034 (USD Million)
7.6. Others
7.6.1. France Immunoassay Market, by Others, 2020–2034 (USD Million)
8. France Immunoassay Market, by Application
8.1. Key Findings
8.2. Introduction
8.2.1. France Immunoassay Market, by Application, 2020-2034 (USD Million)
8.3. Infectious Disease Testing
8.3.1. France Immunoassay Market, by Infectious Disease Testing, 2020–2034 (USD Million)
8.4. Cardiology
8.4.1. France Immunoassay Market, by Cardiology, 2020–2034 (USD Million)
8.5. Oncology
8.5.1. France Immunoassay Market, by Oncology, 2020–2034 (USD Million)
8.6. Endocrinology
8.6.1. France Immunoassay Market, by Endocrinology, 2020–2034 (USD Million)
8.7. Autoimmune Diseases
8.7.1. France Immunoassay Market, by Autoimmune Diseases, 2020–2034 (USD Million)
8.8. Therapeutic Drug Monitoring
8.8.1. France Immunoassay Market, by Therapeutic Drug Monitoring, 2020–2034 (USD Million)
8.9. Others
8.9.1. France Immunoassay Market, by Others, 2020–2034 (USD Million)
9. France Immunoassay Market, by End Use
9.1. Key Findings
9.2. Introduction
9.2.1. France Immunoassay Market, by End Use, 2020-2034 (USD Million)
9.3. Hospitals
9.3.1. France Immunoassay Market, by Hospitals, 2020-2034 (USD Million)
9.4. Laboratories
9.4.1. France Immunoassay Market, by Laboratories, 2020-2034 (USD Million)
9.5. Others
9.5.1. France Immunoassay Market, by Others, 2020-2034 (USD Million)
10. Competitive Landscape
10.1. Expansion and Acquisition Analysis
10.1.1. Expansion
10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
11.1. AAZ-LMB
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Recent Development
11.2. Beckman Coulter
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Benchmarking
11.2.4. Recent Development
11.3. bioMérieux SA
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Benchmarking
11.3.4. Recent Development
11.4. DIAGAST
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Benchmarking
11.4.4. Recent Development
11.5. ELITechGroup SAS
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Benchmarking
11.5.4. Recent Development
11.6. Eurobio Scientific SA
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Benchmarking
11.6.4. Recent Development
11.7. Innovative Diagnostics
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Benchmarking
11.7.4. Recent Development
11.8. NG Biotech
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Benchmarking
11.8.4. Recent Development
11.9. Sebia SAS
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Benchmarking
11.9.4. Recent Development
11.10. VedaLab
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Benchmarking
11.10.4. Recent Development

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us